Marinus Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Marinus Pharmaceuticals's past years’ income statements indicate that its last revenue has increased compared to the previous period by 22% to $30,989,000. Profit margin reached -456%. Total operating expenses were $160,540,000.
Profit Margin
| 2014 | 0 | -10.83M | |
|---|---|---|---|
| 2015 | 0 | -24.85M | |
| 2016 | 0 | -28.64M | |
| 2017 | 0 | -18.89M | |
| 2018 | 0 | -36.72M | |
| 2019 | 0 | -53.76M | |
| 2020 | 1.71M | -66.64M | -3879.05% |
| 2021 | 15.34M | -101.66M | -662.5% |
| 2022 | 25.47M | -19.81M | -77.78% |
| 2023 | 30.98M | -141.40M | -456.31% |
MRNS Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 30.98M | 25.47M | 15.34M | 1.71M | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 1.93M | 340K | 1.47M | 50.50M | 503K | 0 | 126K | 0 | 11K | 0 |
Gross profit | 29.05M | 25.13M | 13.86M | -48.78M | -503K | 0 | -126K | 0 | -11K | 0 |
Operating exp. | ||||||||||
Research and development | 99.38M | 79.91M | 73.52M | 51.10M | 42.96M | 28.39M | 12.37M | 22.00M | 18.91M | 8.69M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 160.54M | 137.92M | 110.79M | 69.65M | 54.42M | 37.17M | 19.04M | 28.24M | 24.43M | 11.92M |
Operating income | -131.48M | -112.78M | -96.93M | -67.93M | -54.42M | -37.17M | -19.04M | -28.24M | -24.43M | -11.92M |
Other income (expenses), net | -11.45M | 96.36M | -1.84M | 462K | 301K | -1K | 145K | -65K | -418K | 1.08M |
Income before tax | -142.94M | -16.42M | -98.77M | -67.47M | -54.12M | -36.72M | -18.89M | -28.64M | -24.85M | -10.83M |
Income tax expense | -1.53M | 3.38M | 2.88M | -833K | -354K | 453K | 13K | 399K | 468K | 1.30M |
Net income | -141.40M | -19.81M | -101.66M | -66.64M | -53.76M | -36.72M | -18.89M | -28.64M | -24.85M | -10.83M |
Earnings per share | ||||||||||
Basic EPS | -2.63 | -0.51 | -2.77 | -2.44 | -3.95 | -3.59 | -3.21 | -5.88 | -6.66 | -7.04 |
Diluted EPS | -2.63 | -0.51 | -2.77 | -2.44 | -3.95 | -3.59 | -3.21 | -5.88 | -6.66 | -7.04 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |